{"id":"ct-gel","safety":{"commonSideEffects":[{"rate":null,"effect":"Local skin irritation"},{"rate":null,"effect":"Contact dermatitis"},{"rate":null,"effect":"Erythema"}]},"_chembl":{"chemblId":"CHEMBL4297274","moleculeType":"Small molecule","molecularWeight":"533.80"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"CT Gel likely contains chlortetracycline or a similar broad-spectrum antimicrobial agent in a gel vehicle optimized for topical delivery. The formulation is intended to provide sustained antimicrobial activity against pathogenic bacteria while maintaining skin tolerability for chronic or recurrent infections.","oneSentence":"CT Gel is a topical antimicrobial gel formulation designed to reduce bacterial colonization and biofilm formation on skin surfaces.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:08:03.840Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Bacterial skin infections or colonization (specific indication pending phase 3 completion)"}]},"trialDetails":[{"nctId":"NCT06169124","phase":"PHASE2","title":"Study to Test the Drug Darolutamide Along With the Drugs Leuprolide Acetate and Exemestane in Patients With Recurrent Ovarian Granulosa Cell Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-02-08","conditions":"Adult Ovarian Granulosa Cell Tumor","enrollment":37},{"nctId":"NCT07466498","phase":"PHASE2","title":"Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP Trial","status":"NOT_YET_RECRUITING","sponsor":"University of Washington","startDate":"2026-08-01","conditions":"Castration-Sensitive Prostate Adenocarcinoma, Metastatic Castration-Sensitive Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8","enrollment":60},{"nctId":"NCT02780128","phase":"PHASE1","title":"Next Generation Personalized Neuroblastoma Therapy","status":"TERMINATED","sponsor":"Yael P Mosse","startDate":"2016-07","conditions":"Neuroblastoma, Cancer","enrollment":66},{"nctId":"NCT07455903","phase":"PHASE2","title":"Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT","status":"NOT_YET_RECRUITING","sponsor":"Baptist Health South Florida","startDate":"2026-04","conditions":"Prostate Cancer, Localized Prostate Carcinoma","enrollment":50},{"nctId":"NCT04423211","phase":"PHASE3","title":"Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging","status":"RECRUITING","sponsor":"ECOG-ACRIN Cancer Research Group","startDate":"2020-10-08","conditions":"Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma, Prostate Adenocarcinoma","enrollment":804},{"nctId":"NCT06305598","phase":"PHASE1","title":"Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate Cancer","status":"RECRUITING","sponsor":"Roswell Park Cancer Institute","startDate":"2024-12-19","conditions":"Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8","enrollment":14},{"nctId":"NCT05901610","phase":"NA","title":"Decision Making in Chronic Pain and Alcohol Use Disorder","status":"SUSPENDED","sponsor":"Virginia Polytechnic Institute and State University","startDate":"2024-06-28","conditions":"Alcohol Use Disorder, Chronic Pain","enrollment":10},{"nctId":"NCT07196696","phase":"NA","title":"An in Vivo CT Imaging Study of GMA-Tulip, I-gel, and LMA Supreme (GLAM-II)","status":"RECRUITING","sponsor":"Zhejiang Cancer Hospital","startDate":"2025-10-12","conditions":"Supraglottic Airway Device","enrollment":9},{"nctId":"NCT05669664","phase":"PHASE2","title":"Testing the Anti-cancer Drug Darolutamide in Patients With Testosterone-Driven Salivary Gland Cancers","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2023-07-20","conditions":"Locally Advanced Salivary Gland Carcinoma, Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma","enrollment":21},{"nctId":"NCT06922318","phase":"PHASE2","title":"The COSMYC Trial (COmbined Suppression of MYC)","status":"RECRUITING","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2025-08-19","conditions":"Metastatic Castration-resistant Prostate Cancer","enrollment":50},{"nctId":"NCT06866262","phase":"PHASE1, PHASE2","title":"Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Kidney Cell Cancer, ICON Trial","status":"RECRUITING","sponsor":"University of Michigan Rogel Cancer Center","startDate":"2025-08-15","conditions":"Locally Advanced Clear Cell Renal Cell Carcinoma, Locally Advanced Sarcomatoid Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma","enrollment":55},{"nctId":"NCT06971783","phase":"NA","title":"Effect of an Experimental Gel Based on Acmella Oleracea Extract Associated or Not With Fluoride on Dentin Hypersensitivity","status":"COMPLETED","sponsor":"Universidade Federal do Para","startDate":"2024-08-20","conditions":"Dentin Desensitizers, Non-carious Cervical Lesions, Dentin Hypersensitivity","enrollment":100},{"nctId":"NCT04302454","phase":"PHASE3","title":"Androgen Deprivation Therapy for Oligo-recurrent Prostate Cancer in Addition to radioTherapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Medical Center Groningen","startDate":"2020-03-19","conditions":"Prostate Cancer","enrollment":280},{"nctId":"NCT06446635","phase":"NA","title":"Semiflex Assisted Vacuum Therapy for Perianal Abscesses/Sinuses and Fistula: a Pilot Study","status":"RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2023-04-14","conditions":"Perianal Fistula, Perianal Fistula Due to Crohn's Disease, Perianal Abscess","enrollment":40},{"nctId":"NCT05620966","phase":"","title":"EEG to Diagnose TIA and Stroke","status":"COMPLETED","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2022-10-24","conditions":"Stroke, Transient Ischemic Attack","enrollment":21},{"nctId":"NCT02803905","phase":"PHASE2","title":"Islet Transplant Alone in OMENtum","status":"UNKNOWN","sponsor":"Lorenzo Piemonti","startDate":"2016-04","conditions":"Islets of Langerhans Transplantation, Diabetes Mellitus, Type 1","enrollment":12},{"nctId":"NCT06090058","phase":"","title":"NF-L Chain Measurement in Acute Ischemic Stroke","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2023-11-01","conditions":"Acute Stroke","enrollment":150},{"nctId":"NCT05978752","phase":"NA","title":"Clinical Study on Endoscopic Management of GOV1 Esophagogastric Varices","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2023-12","conditions":"Esophageal and Gastric Varices","enrollment":57},{"nctId":"NCT05738941","phase":"","title":"Interventional Radiology in Bony Lesions","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2025-03-01","conditions":"Bone Lesion","enrollment":50},{"nctId":"NCT04721457","phase":"PHASE4","title":"The Efficacy of Pre-procedural Mouth Rinses on COVID-19 Saliva Viral Load","status":"COMPLETED","sponsor":"King Abdulaziz University","startDate":"2021-01-03","conditions":"SARS-CoV-2, COVID-19, Mouthwashes","enrollment":90},{"nctId":"NCT04957849","phase":"NA","title":"Acute Hypertensive Cerebral Hemmorrhage Surgery","status":"UNKNOWN","sponsor":"Shanghai Changzheng Hospital","startDate":"2022-01-01","conditions":"Hypertensive Intracerebral Hemorrhage","enrollment":1000},{"nctId":"NCT02005354","phase":"NA","title":"Does Trans-Cutaneous Electrical Nerve Stimulation (TENS) Alleviate The Pain Experienced During Bone Marrow Sampling?","status":"COMPLETED","sponsor":"University Hospital Plymouth NHS Trust","startDate":"2014-02","conditions":"Pain","enrollment":70},{"nctId":"NCT03904303","phase":"PHASE1","title":"Test of a New Gel-based Colon Cleansing Agent Compared to Moviprep","status":"UNKNOWN","sponsor":"Zealand University Hospital","startDate":"2019-06-01","conditions":"Pharmacological Action","enrollment":16},{"nctId":"NCT02911922","phase":"NA","title":"Randomized Trial of Image -Guided Stereotactic Radiation Therapy (IG-SRT) in Prostate Cancer","status":"TERMINATED","sponsor":"Weill Medical College of Cornell University","startDate":"2016-09","conditions":"Prostate Cancer","enrollment":1},{"nctId":"NCT01929278","phase":"PHASE1","title":"W0265-103: A Single-Center, Evaluator-Blinded, Randomized, Placebo Controlled, Phase 1 Clinical Trial Evaluating The Phototoxic Potential Of Topically Applied Clindamycin 1.0% - Tretinoin 0.025% Gel (Ct Gel) In Healthy Volunteers","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2008-12-08","conditions":"Acne Vulgaris","enrollment":37},{"nctId":"NCT01915758","phase":"PHASE1","title":"W0265-104: A Single-Center, Evaluator-Blinded, Randomized, Placebo-Controlled, Phase 1 Clinical Trial Evaluating the Photoallergic Potential of Topically Applied Clindamycin Phosphate 1.0% and Tretinoin 0.025% (CT Gel) in Healthy Volunteers","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-11-21","conditions":"Acne Vulgaris","enrollment":64},{"nctId":"NCT00689117","phase":"PHASE3","title":"A Clinical Study to Evaluate the Safety and Effectiveness of an Investigational Product Called CT Gel","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2008-04","conditions":"Acne Vulgaris, Acne","enrollment":1649},{"nctId":"NCT00891982","phase":"PHASE3","title":"A Clinical Study to Evaluate the Tolerability of a Topical Antibiotic and Retinoid Used in a Combined Regimen With a BPO Wash","status":"COMPLETED","sponsor":"Stiefel, a GSK Company","startDate":"2009-04-01","conditions":"Acne Vulgaris","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":28,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"CT Gel","genericName":"CT Gel","companyName":"Stiefel, a GSK Company","companyId":"stiefel-a-gsk-company","modality":"Small molecule","firstApprovalDate":"","aiSummary":"CT Gel is a small molecule modality, specifically a compound known as CT 2584. It is being studied in various clinical trials for conditions including acute stroke, hypertensive intracerebral hemorrhage, prostate cancer, and metastatic castration-resistant prostate cancer.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}